Panel Backs Device to Track Blood Sugar
From Times Wire Reports
A Food and Drug Administration advisory panel recommended approval of a new wearable monitor to measure the blood sugar levels of diabetics, most of whom do not have their disease under control. While backing MiniMed Inc.’s Continuous Glucose Monitoring System, which can take up to 288 measurements every 24 hours, the panel said more study is needed on how it works in some types of diabetics and some ethnic groups.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
